Position in RCEL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,192,561
+$467,602 QoQ
Shares Held
1,133,126
+4.9% QoQ
Ownership
3.68%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026BlackRock, Inc. holds $66,749,395,307 across 112 Medical Devices names. RCEL ranks #78 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
145,687,458 | $14,957,731,302 | |
| 2 | MDT |
Medtronic plc
|
113,182,567 | $9,807,269,421 | |
| 3 | SYK |
Stryker Corp
|
27,602,049 | $9,069,757,269 | |
| 4 | BSX |
Boston Scientific Corp
|
131,822,037 | $8,271,832,814 | |
| 5 | EW |
Edwards Lifesciences Corp
|
52,590,933 | $4,211,481,905 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
35,984,327 | $2,561,364,385 | |
| 7 | DXCM |
Dexcom Inc
|
38,964,371 | $2,446,962,491 | |
| 8 | STE |
STERIS plc
|
9,026,621 | $1,996,056,695 |
All Filings in RCEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,192,561 | 1,133,126 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,724,959 | 1,079,699 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,817,405 | 1,138,436 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,028,011 | 1,895,655 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $15,052,866 | 1,849,247 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $23,918,116 | 1,868,603 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $19,944,760 | 1,860,519 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||